Apraxia of lid opening: A review

Neurology

Volumn 48, Issue 6, 1997, Pages 1491-1494

  Boghen, Dan ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; LEVODOPA; VALPROIC ACID;

ACANTHOCYTOSIS; APRAXIA; BLEPHAROSPASM; CLINICAL FEATURE; DISEASE ASSOCIATION; EXTRAPYRAMIDAL SYNDROME; EYELID DISEASE; EYELID MOVEMENT; HUMAN; HUNTINGTON CHOREA; MOTOR NEURON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STROKE; SYNDROME; WILSON DISEASE;

EID: 0030878314     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.6.1491     Document Type: Review

References (43)

1. Goldstein JE, Cogan DG. Apraxia of lid opening. Arch Ophthalmol 1965;73:155-159.
2. Schilder P. Neuer Beitrag zur Pathologie der Lidbewengungen. Dtsch Z Nervenheilk 1927;98:161-168.
3. Riese W. Apraxie der lidoffhung (analyse einer bewegungsstorung). J Psychol Neurol Lpz 1930;40:347-355.
4. Lepore FE, Duvoisin RC. "Apraxia" of eyelid opening: an involuntary levator inhibition. Neurology 1985;35:423-427.
5. Brusa A, Meneghini S, Piccardo A, Stehr R. Apraxia of lid opening. Ital J Neurol Sci 1981;4:367-370.
6. Brusa A, Mancardi G, Brusa A, et al. "Apraxia" of eye opening in idiopathic Parkinson's disease [letter]. Neurology 1986;36: 134.
7. Krack P, Marion MH. "Apraxia of lid opening," a focal eyelid dystonia: clinical study of 32 patients. Mov Disord 1994;9: 610-615.
8. Lepore FE. So-called apraxias of lid movement. Adv Neurol 1988;49:85-90.
9. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine analog synthesis. Science 1983;249:979-980.
10. Dehaene I, Bogaerts M. La paralysie supranucléaire progressive. A propos d'un cas avec "apraxie de l'ouverture des yeux" et réaction favorable au traitement par L-dopa. Acta Neurol Belg 1971;71:141-145.
11. Brusa A, Mancardi G, Bugiani O. Progressive supranuclear palsy 1979. Ital J Neurol Sci 1980;18:349-356.
12. Dehaene I. Apraxia of eyelid-opening in progressive supranuclear palsy. Ann Neurol 1984;15:115-116.
13. Golbe LI, Davis PA, Lepore FE. Eyelid movement abnormalities in progressive supranuclear palsy. Mov Disord 1989;4: 297-302.
14. Friedman DI, Jankovic J, McCrary JA. Neuro-ophthalmic findings in progressive supranuclear palsy. J Clin Neuroophthalmol 1992;12:104-109.
15. Nutt JG. Lid abnormalities secondary to cerebral hemisphere lesions. Ann Neurol 1977;1:149-151.
16. De Renzi E, Gentilini M, Bazolli C. Eyelid movement disorders and motor impersistence in acute hemisphere disease. Neurology 1986;36:414-418.
17. Lepore FE. Bilateral cerebral ptosis. Neurology 1987;37:1043-1046.
18. Johnston JC, Rosenbaum DM, Picone CM, Grotta JC. Apraxia of eyelid opening secondary to right hemisphere infarction. Ann Neurol 1989;25:622-624.
19. Bonaventura I, Matias-Guiu J, Cervera C, Puiggros AC. Neuroacanthocytosis syndrome, apraxia of eyelid opening, and progressive supranuelear palsy [letter]. Neurology 1986;36: 1276.
20. Keane JE. Lid-opening apraxia in Wilson's disease. J Clin Neuro-ophthalmol 1988;8:31-33.
21. Abe K, Fujimura H, Tatsumi C, Toyooka K, Yorifuji S, Yanagihara T. Eyelid "apraxia" in patients with motor neuron disease. J Neurol Neurosurg Psychiatry 1995;59:629-632.
22. Boghen D. Involuntary movements of the face. American Academy of Neurology course, Toronto, April 1981.
23. Jordan DR, Anderson RL, Digre KB. Apraxia of lid opening in blepharospasm. Ophthalmic Surg 1990;21:331-234.
24. Tolosa E, Kulisevsky J, Marti MJ. "Apraxia" of lid opening (ALO) in essential blepharospasm (EBSP) [abstract]. Neurology 1987;37(suppl 1):273.
25. Elston JS. A new variant of blepharospasm. J Neurol Neurosci Psychiatry 1992;55:369-371.
26. Chand RP, Park DM. Atypical blepharospasm responsive to sodium valproate [letter]. Mov Disord 1994;9:116-117.
27. Dewey RB Jr, Maraganore DM. Isolated eyelid-opening apraxia: report of a new levodopa-responsive syndrome. Neurology 1994;44:1752-1754.
28. Estaban A, Giménez-Roldan S. Involuntary closure of eyelids in parkinsonism: electrophysiologic evidence for prolonged inhibition of the levator palpebrae muscles. J Neurosci 1988;85: 333-345.
29. Jankovic J. Apraxia of eyelid opening in progressive supranuclear palsy [reply]. Ann Neurol 1984;15:115-116.
30. Case records of the Massachusetts General Hospital. Case 32-1975. N Engl J Med 1975;293:346-352.
31. Geschwind N. The apraxias: neural mechanism of disorder of learned movement. Am Sci 1975;63:188-195.
32. Aramideh M, Ongeboer De Visser BW, Koelman JHTM, Speelman JD. Motor persistence of orbicularis oculi muscle in eyelid-opening disorders. Neurology 1995;45:897-902.
33. Jankovic J, Patel SC. Blepharospasm associated with brainstem lesions. Neurology 1983;33:1237-1240.
34. Nashold BS, Gills JP. Ocular signs from brain stimulation and lesions. Arch Ophthalmol 1967;77:609-618.
35. Smith D, Ishikawa T, Dhawan V, Winterkorn JS, Eidelberg D. Lid opening apraxia is associated with medial frontal hypometabolism. Mov Disord 1995;10:341-344.
36. Adair JC, Williamson DJG, Heilman KM. Eyelid opening apraxia in focal cortical degeneration [letter]. J Neurol Neurosurg Psychiatry 1995;58:508-509.
37. Aramideh M, Ongeboer De Visser BW, Devriese PP, Bour LJ, Speelman JD. Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm. Brain 1994;117:27-38.
38. Loeffler JD, Slatt B, Hoyt WF. Motor abnormalities of the eyelids in Parkinson's disease. Arch Ophthalmol 1966;76:178-185.
39. Newman SA, Slavin M, Phillips L. Apraxia of eyelid opening: a cause of botulinum failure. Presented at the North American Neuro-Ophthalmology Society, Crested Butte, CO, 1988.
40. Katz BB, Rosenberg JH. Botulinum therapy for apraxia of eyelid opening. Am J Ophthalmol 1987;103:718-719.
41. Jankovic J. Apraxia of lid opening [letter]. Mov Disord 1995; 10:686.
42. Lepore V, Defazio G, Acquistapace D, et al. Botulinum A toxin for the so-called apraxia of lid opening [letter]. Mov Disord 1995;10:525-256.
43. Anderson RL. Ask the doctor. Benign Essential Blepharospasm Research Foundation Newsletter 1996;15:3.